Sidoti Events, LLC's Virtual September Small-Cap Conference
STAAR Surgical (NASDAQ:STAA) Has Some Way To Go To Become A Multi-Bagger
Baillie Gifford Reduces Stake in Staar Surgical Co
Staar Surgical Price Target Cut to $44.00/Share From $50.00 by Stifel
Stifel Maintains Staar Surgical(STAA.US) With Buy Rating, Cuts Target Price to $44
Express News | STAAR Surgical Co : Stifel Cuts Target Price to $44 From $50
CCORF Maintains Staar Surgical(STAA.US) With Hold Rating, Maintains Target Price $41
Analysts Conflicted on These Healthcare Names: Merus (MRUS), Staar Surgical (STAA) and Rani Therapeutics Holdings (RANI)
Implied Volatility Surging for STAAR Surgical (STAA) Stock Options
STAAR Surgical To Present At Canaccord Genuity Growth Conference; Webcast At 8:30 AM ET
The Three-year Loss for STAAR Surgical (NASDAQ:STAA) Shareholders Likely Driven by Its Shrinking Earnings
Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Staar Surgical (STAA) and Organon (OGN)
STAAR Surgical Second Quarter 2024 Earnings: EPS: US$0.15 (Vs US$0.13 in 2Q 2023)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Staar Surgical (STAA), Cadrenal Therapeutics, Inc. (CVKD) and Allogene Therapeutics (ALLO)
A Glimpse Into The Expert Outlook On Staar Surgical Through 4 Analysts
Staar Surgical Hold Rating: Solid Performance Amid Global Economic Uncertainty and China Market Concerns
Express News | Canaccord Genuity Maintains Hold on Staar Surgical, Lowers Price Target to $41
Analysts Offer Insights on Healthcare Companies: Amneal Pharmaceuticals (AMRX), Staar Surgical (STAA) and Pliant Therapeutics (PLRX)
Staar Surgical Analyst Ratings
Staar Surgical (STAA) Gets a Hold From Needham